We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-20.71%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$774M
AUM Growth
-$95.8M
Cap. Flow
+$87.6M
Cap. Flow %
11.31%
Top 10 Hldgs %
36.91%
Holding
173
New
42
Increased
36
Reduced
22
Closed
32

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$30.4M
2
VYX icon
NCR Voyix
VYX
+$22.2M
3
ZEN
ZENDESK INC
ZEN
+$21.5M
4
BHC icon
Bausch Health
BHC
+$21.3M
5
WBD icon
Warner Bros
WBD
+$20.9M

Top Sells

Rank Stock Value
1
EPAY
Bottomline Technologies Inc
EPAY
+$27.8M
2
VMW
VMware, Inc
VMW
+$11.5M
3
BBWI icon
Bath & Body Works
BBWI
+$11.3M
4
T icon
AT&T
T
+$10.3M
5
KAHC.U
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
+$9.96M

Sector Composition

Rank Sector Weight
1 Technology 28.61%
2 Communication Services 14.38%
3 Industrials 14.35%
4 Healthcare 13.55%
5 Consumer Discretionary 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMX icon
101
Fomento Económico Mexicano
FMX
$44.8B
$739K 0.1%
10,951
-5,949
-35% -$440K
ORGN
102
DELISTED
Origin Materials
ORGN
$709K 0.09%
4,614
-15,424
-77% -$2.94M
NAUT icon
103
Nautilus Biotechnolgy
NAUT
$213M
$706K 0.09%
262,360
+15,647
+6% +$58.2K
LYRA
104
DELISTED
LYRA THERAPEUTICS INC
LYRA
$673K 0.09%
2,383
-15
-0.6% -$4.08K
VINC
105
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$597K 0.08%
22,609
+1,976
+10% +$87.9K
ACHV icon
106
Achieve Life Sciences
ACHV
$629M
$586K 0.08%
120,094
– –
QUOT
107
DELISTED
Quotient Technology Inc
QUOT
$580K 0.07%
195,436
+52,963
+37% +$251K
GT icon
108
Goodyear
GT
$2.03B
$573K 0.07%
53,506
-150,858
-74% -$1.89M
CCO icon
109
Clear Channel Outdoor Holdings
CCO
$1.23B
$501K 0.06%
+468,072
New +$981K
QSI icon
110
Quantum-Si Incorporated
QSI
$171M
$492K 0.06%
211,900
+119,432
+129% +$457K
LIVN icon
111
LivaNova
LIVN
$4.39B
$438K 0.06%
+7,004
New +$496K
ORGNW
112
DELISTED
Origin Materials Inc Warrants
ORGNW
$433K 0.06%
428,993
– –
FIS icon
113
Fidelity National Information Services
FIS
$22.5B
$404K 0.05%
4,404
– –
DOCU
114
DocuSign
DOCU
$10.4B
$402K 0.05%
+7,009
New +$567K
ZUO
115
DELISTED
Zuora, Inc.
ZUO
$391K 0.05%
+43,714
New +$486K
SPLK
116
DELISTED
Splunk Inc
SPLK
$385K 0.05%
+4,354
New +$479K
CTMX icon
117
CytomX Therapeutics
CTMX
$729M
$360K 0.05%
196,583
+5,983
+3% +$11.5K
GBTG.WS
118
DELISTED
Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GBTG.WS
$352K 0.05%
+335,025
New +$389K
LNSR icon
119
LENSAR
LNSR
$66.6M
$345K 0.04%
52,950
– –
RCEL icon
120
Avita Medical
RCEL
$147M
$239K 0.03%
50,343
– –
TSAT icon
121
Telesat
TSAT
$560M
$236K 0.03%
21,129
-7,064
-25% -$99.6K
PAYO icon
122
Payoneer
PAYO
$2.41B
$210K 0.03%
53,522
– –
GBTG icon
123
American Express Global Business Travel
GBTG
$4.93B
$191K 0.02%
+30,327
New +$266K
ROIVW
124
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$191K 0.02%
318,791
– –
NRDY.WS
125
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$154K 0.02%
510,400
– –
3 4
5
6 7

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Clearline Capital held 173 positions worth $774M, down 11% from $870M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Clearline Capital deployed $87.6M of net new capital in Q2 2022, opening 42 new positions and adding to 36 existing holdings. Its largest new stake was Amazon: 243,180 shares worth $25.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $4.53M trimmed.

  • Clearline Capital's largest Q2 2022 buy was Amazon: 243,180 shares worth $25.8M.
  • Clearline Capital added most to NCR Voyix in Q2 2022, an estimated $22.2M increase.
  • Clearline Capital's biggest Q2 2022 reduction was Cardinal Health, cutting an estimated $4.53M.
  • Clearline Capital fully exited Bottomline Technologies Inc in Q2 2022, selling an estimated $27.8M.
  • Clearline Capital's ten largest holdings make up 37% of its $774M portfolio in Q2 2022.
  • Clearline Capital opened 42 new positions and closed 32 in Q2 2022.
  • Clearline Capital's portfolio value fell 11% quarter-over-quarter to $774M.

Based on Clearline Capital's 13F filing for Q2 2022, filed 15 Aug 2022.